---
title: "Crescent Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/251003846.md"
description: "Completed Merger with GlycoMimetics and Previously Announced $200 Million Private Financing Supporting Pipeline of Next Generation Therapeutics for Solid Tumors ..."
datetime: "2025-07-31T12:37:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/251003846.md)
  - [en](https://longbridge.com/en/news/251003846.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/251003846.md)
---

# Crescent Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Completed Merger with GlycoMimetics and Previously Announced $200 Million Private Financing Supporting Pipeline of Next Generation Therapeutics for Solid Tumors ...

### Related Stocks

- [GLYC.US](https://longbridge.com/en/quote/GLYC.US.md)
- [CBIO.US](https://longbridge.com/en/quote/CBIO.US.md)

## Related News & Research

- [Want to own SpaceX stock before its blockbuster IPO? Here are 3 ways investors can buy right now.](https://longbridge.com/en/news/282411004.md)
- [CrowdStrike Is Joining Anthropic’s New Project Glasswing. Does That Make CRWD Stock a Buy?](https://longbridge.com/en/news/282447694.md)
- [What to Expect From Equity Residential’s Next Quarterly Earnings Report](https://longbridge.com/en/news/282487568.md)
- ["Move To California": Nvidia CEO Becomes Unofficial Pitchman For Struggling Left-Wing State](https://longbridge.com/en/news/282394413.md)
- ['This Isn't the Time,' Says Investor About Microsoft Stock (MSFT)](https://longbridge.com/en/news/282458473.md)